Revenue · 2017–2025
Arcus Biosciences revenue
$247M−4.3% · FY2025
Arcus Biosciences (RCUS) reported $247M in revenue for fiscal 2025, −4.3% year on year.
2018–2021 missing from the revenue series. In those years the company tagged only part of its revenue in XBRL: the tag it used is 7.50 times smaller than its total revenue in the latest year. Showing those figures next to the later ones would draw a jump that never happened, so they are left out rather than shown.
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +90.7%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Arcus Biosciences revenue |url=https://companiesranked.com/en/company/arcus-biosciences/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Arcus Biosciences revenue. CompaniesRanked. https://companiesranked.com/en/company/arcus-biosciences/revenueBibTeX
@misc{companiesranked-en-company-arcus-biosciences-revenue-2026,
author = {{CompaniesRanked}},
title = {{Arcus Biosciences revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/arcus-biosciences/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001724521-26-000009 · February 25, 2026
{{cite web |title=Arcus Biosciences revenue — 10-K (0001724521-26-000009) |url=https://www.sec.gov/Archives/edgar/data/1724521/000172452126000009/rcus-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-25}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.